• GLT-1 Upregulation Mitigates TBI-Induced Cognitive Dysfuncti

  2026-07-23

  This study uncovers how upregulating GLT-1 expression attenuates neuronal apoptosis and cognitive impairment in mice following traumatic brain injury (TBI) by inhibiting the CB1-CREB signaling pathway. The findings offer mechanistic insight into glutamate homeostasis disruption post-TBI and highlight the therapeutic potential of targeting the endocannabinoid system to protect neural function.

• Pcbp1 Maintains Mitochondrial Integrity for B Cell Antibody

  2026-07-23

  The reference study uncovers how the RNA binding protein Pcbp1 preserves mitochondrial integrity to enable efficient antibody production and germinal center formation in B cells. These findings link posttranscriptional regulation of Fdxr mRNA to mitochondrial electron transport chain function, highlighting mechanistic connections between cellular metabolism and humoral immunity.

• Deferiprone in Precision Iron Modulation: Metabolic Insights

  2026-07-22

  Explore how Deferiprone (3-hydroxy-1,2-dimethylpyridin-4-one) enables targeted modulation of cellular iron metabolism, with new insights into enterocyte metabolic reprogramming and advanced applications in apoptosis induction and protection against doxorubicin-induced cytotoxicity. This article delivers a distinct, evidence-based perspective for researchers in cancer biology and beyond.

• SU5416 (Semaxanib): Advancing Angiogenesis Inhibition in Tra

  2026-07-22

  This thought-leadership article explores the dual mechanistic actions and strategic research utility of SU5416 (Semaxanib), a selective VEGFR2 inhibitor and AHR agonist. Integrating the latest mechanistic findings, including novel insight into HIF1α signaling in vascular cells, it offers translational researchers a roadmap for leveraging SU5416 in angiogenesis, tumor biology, and immune modulation studies. The discussion bridges practical protocols, competitive context, and the evolving frontier of vascular-targeted therapeutics, grounded in both recent literature and APExBIO’s expertise.

• Recombinant Mouse IFN-γ: Mechanistic Insights for Antigenici

  2026-07-21

  Explore how Recombinant Mouse IFN-γ enhances antigen presentation and immune function in metabolically-driven liver cancer models. This article uniquely bridges molecular mechanism, recent breakthroughs, and practical assay optimization for immunomodulatory cytokine research.

• Escalating Macrolide Resistance in Mycoplasma pneumoniae: 20

  2026-07-21

  This study systematically evaluated antimicrobial susceptibility in pediatric Mycoplasma pneumoniae isolates from Beijing in 2023, revealing universal resistance to 14- and 15-membered macrolides and highlighting comparatively lower MICs for the 16-membered macrolide acetylspiramycin. The findings reinforce the urgency of resistance surveillance and provide practical benchmarks for antimicrobial resistance research.

• Q-VD-OPh (A1901): Reliable Pan-Caspase Inhibitor for Apoptos

  2026-07-20

  This authoritative guide demonstrates how Q-VD-OPh (SKU A1901) meets core challenges in cell viability, caspase activity inhibition, and apoptosis research. By addressing real-world experimental scenarios with data-backed solutions, it equips biomedical researchers and lab technicians to drive reproducibility and workflow reliability. Discover why Q-VD-OPh from APExBIO is a trusted choice for sensitive, high-impact assays.

• Antibacterial Drug Use and Resistance in Psychiatric Hospita

  2026-07-20

  This study provides a detailed retrospective analysis of antibacterial drug utilization and associated bacterial resistance patterns in a psychiatric hospital during the 2022 COVID-19 epidemic. Its findings highlight both effective stewardship practices and emerging resistance trends, underscoring the need for ongoing monitoring and tailored antimicrobial strategies in psychiatric care settings.

• Cisplatin (A8321): Reliable Apoptosis Induction for Cancer R

  2026-07-19

  This scenario-driven article explores common laboratory challenges in viability assays, xenograft studies, and resistance modeling—demonstrating how Cisplatin (SKU A8321) offers reproducible, literature-backed solutions. Designed for biomedical researchers and lab technicians, it details protocol parameters, data interpretation, and product selection, positioning Cisplatin as a benchmark tool for apoptosis and tumor inhibition workflows.

• Naftifine HCl in Antifungal Models: Beyond Membrane Disrupti

  2026-07-18

  Explore how Naftifine HCl, an allylamine antifungal agent, enables advanced research into fungal membrane biology and assay innovation. This article uniquely integrates molecular mechanism, solubility optimization, and new cross-talk with WNT/GSK3 signaling insights.

• Amine Chemistry in Polymer Micelles Shapes mRNA Delivery Eff

  2026-07-17

  A recent study systematically mapped how the chemical structure of amine groups in polymer micelles governs mRNA binding, in vitro delivery, and lung-selective targeting. Using machine learning and a diverse polymer library, the authors reveal how tuning amine functionality impacts both performance and cell compatibility, providing actionable design rules for next-generation mRNA delivery systems.

• Magnetic Nano-antibodies Generate CAR-T-mimicking Cells In V

  2026-07-17

  This study introduces a magnetic bispecific nano-antibody platform for in vivo generation and magnetic guidance of CAR-T-mimicking cells, directly addressing barriers of T cell infiltration and immunosuppression in solid tumor therapy. The approach demonstrates robust preclinical efficacy, signaling a transformative shift for next-generation, non-genetic immunoengineering.

• L-NMMA Acetate in NOS Pathway Modulation: Applied Workflows

  2026-07-16

  L-NMMA acetate enables precise nitric oxide pathway modulation across inflammation and osteogenic research models. This guide details practical workflows, troubleshooting strategies, and new experimental insights—translating recent discoveries into actionable lab protocols.

• Guanabenz Acetate: Precision α2-Adrenergic Receptor Agonist

  2026-07-16

  Guanabenz Acetate empowers researchers to dissect α2-adrenergic GPCR signaling and stress granule biology with high selectivity and robust workflow support. This guide delivers actionable protocol parameters, troubleshooting, and advanced applications, bridging neuroscience and innate immunity research.

• EZ Cap™ Mouse IL-12 mRNA (m1Ψ): Engineering Precision Immuno

  2026-07-15

  Discover how EZ Cap™ Mouse IL-12 mRNA (m1Ψ) empowers precision immunotherapy research with advanced stabilization, efficient translation, and minimized immunogenicity. This in-depth analysis reveals the latest scientific innovations and practical assay guidance for extrahepatic delivery of cytokine mRNA.

446 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page